UNITED HEALTHCARE CORP
S-3, 1996-05-23
HOSPITAL & MEDICAL SERVICE PLANS
Previous: SPECTRASCIENCE INC, S-8, 1996-05-23
Next: QUESTRON TECHNOLOGY INC, 10QSB, 1996-05-23



<PAGE>
     As filed with the Securities and Exchange Commission on May 23, 1996
                                                      Registration No. 333-
================================================================================
                      SECURITIES AND EXCHANGE COMMISSION
                            Washington, D.C. 20549
 
                             --------------------

                                   FORM S-3
                            REGISTRATION STATEMENT
                                     Under
                          The Securities Act of 1933

                             --------------------
 
                         UNITED HEALTHCARE CORPORATION
            (Exact name of registrant as specified in its charter)

        Minnesota                                         41-1321939
(State or other jurisdiction of            (I.R.S. Employer Identification No.) 
incorporation or organization)

                                300 Opus Center
                              9900 Bren Road East
                          Minnetonka, Minnesota 55343
                                (612) 936-1300
  (Address, including zip code, and telephone number, including area code, of
                   registrant's principal executive offices)

                             Kevin H. Roche, Esq.
                         Secretary and General Counsel
                         United HealthCare Corporation
                                300 Opus Center
                              9900 Bren Road East
                          Minnetonka, Minnesota 55343
                                (612) 936-1736
(Name, address, including zip code, and telephone number, including area code,
                             of agent for service)

                                   Copy to:
                                David J. Lubben
                             Dorsey & Whitney LLP
                            220 South Sixth Street
                         Minneapolis, Minnesota 55402
                                (612) 340-2600
 
   Approximate date of commencement of proposed sale to the public: From time to
time after the effective date of this Registration Statement.

   If the only securities being registered on this Form are being offered
pursuant to dividend or interest reinvestment plans, please check the following
box. [_]

   If any of the securities being registered on this Form are to be offered on a
delayed or continuous basis pursuant to Rule 415 under the Securities Act of
1933, other than securities offered only in connection with dividend or interest
reinvestment plans, check the following box. [X]

   If this Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, please check the following box
and list the Securities Act registration statement number of the earlier
effective registration statement for the same offering. [_]

   If this Form is a post-effective amendment filed pursuant to Rule 462(c)
under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. [_]

   If delivery of the prospectus is expected to be made pursuant to Rule 434,
please check the following box. [_]

                        CALCULATION OF REGISTRATION FEE
================================================================================
                                    Proposed         Proposed
  Title of Each        Amount        Maximum         Maximum        Amount of
Class of Securities    to be      Offering Price     Aggregate     Registration
 to be Registered    Registered     Per Share*    Offering Price*       Fee
- --------------------------------------------------------------------------------
 Common Stock
  ($.01 par value)  22,135 shares     $53.75       $1,189,757        $411
================================================================================
*  Estimated solely for purposes of computing the registration fee, pursuant to
   Rule 457(g) and Rule 457(c), and based upon the average of the high and low
   sales prices for such Common Stock on May 21, 1996, as reported on the New
   York Stock Exchange.
                             --------------------

   THE REGISTRANT HEREBY AMENDS THIS REGISTRATION STATEMENT ON SUCH DATE OR
DATES AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL THE REGISTRANT SHALL
FILE A FURTHER AMENDMENT WHICH SPECIFICALLY STATES THAT THIS REGISTRATION
STATEMENT SHALL THEREAFTER BECOME EFFECTIVE IN ACCORDANCE WITH SECTION 8(a) OF
THE SECURITIES ACT OF 1933 OR UNTIL THE REGISTRATION STATEMENT SHALL BECOME
EFFECTIVE ON SUCH DATE AS THE COMMISSION, ACTING PURSUANT TO SAID SECTION 8(a),
MAY DETERMINE.
=============================================================================== 
<PAGE>
 

                                                                      PROSPECTUS


                         UNITED HEALTHCARE CORPORATION

                                 ------------

                                 22,135 SHARES
                                      OF
                                 COMMON STOCK
                               ($.01 PAR VALUE)

                                 ------------


      In accordance with the applicable rules of the Securities and Exchange
   Commission, this Prospectus may be used in connection with separate offerings
   of the Common Stock of United HealthCare Corporation (the "Company").

      This Prospectus relates to the issuance by the Company of up to 22,135
   shares of Common Stock, par value $.01 per share, of the Company (the "Common
   Stock") issuable upon the exercise of outstanding warrants assumed by the
   Company in connection with its merger with HealthWise of America, Inc.
   ("HealthWise").  The warrants are exercisable at negotiated prices.

      The Common Stock is traded on the New York Stock Exchange.  On May __,
   1996, the closing price of the Common Stock as reported on the New York Stock
   Exchange was $_____ per share.

                             --------------------

   THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES
        AND EXCHANGE COMMISSION OR ANY STATE SECURITIES COMMISSION NOR
            HAS THE SECURITIES AND EXCHANGE COMMISSION OR ANY STATE
               SECURITIES COMMISSION PASSED UPON THE ACCURACY OR
               ADEQUACY OF THIS PROSPECTUS.  ANY REPRESENTATION
                    TO THE CONTRARY IS A CRIMINAL OFFENSE.

                             --------------------

      No person has been authorized to give any information or to make any
   representations other than those contained in this Prospectus in connection
   with the offer contained herein, and, if given or made, such information or
   representations must not be relied upon as having been authorized by the
   Company. This Prospectus does not constitute an offer to sell, or a
   solicitation of an offer to buy, any securities offered hereby in any
   jurisdiction in which it is not lawful or to any person to whom it is not
   lawful to make any such offer or solicitation. Neither the delivery of this
   Prospectus nor any sale made hereunder shall, under any circumstances, create
   any implication that information herein is correct as of any time subsequent
   to the date hereof.

                 The date of this Prospectus is May __, 1996.
<PAGE>
 

                             AVAILABLE INFORMATION

      The Company is subject to the informational requirements of the Securities
   Exchange Act of 1934, as amended (the "Exchange Act"), and in accordance
   therewith files reports, proxy statements and other information with the
   Securities and Exchange Commission (the "Commission"). Such reports, proxy
   statements and other information filed by the Company can be inspected and
   copied at the public reference facilities of the Commission at 450 Fifth
   Street, N.W., Washington, D.C. 20549, and at the Commission's regional
   offices at 7 World Trade Center, Suite 1300, New York, New York 10048 and
   CitiCorp Center, 500 West Madison Street, Suite 1400, Chicago, Illinois
   60661. Copies of such materials can be obtained from the Public Reference
   Section of the Commission at 450 Fifth Street, N.W., Washington, D.C. 20549,
   at prescribed rates. In addition, the Common Stock of the Company is listed
   on the New York Stock Exchange, and reports, proxy statements and other
   information concerning the Company can also be inspected at the offices of
   the New York Stock Exchange, 20 Broad Street, New York, New York 10005. This
   Prospectus does not contain all the information set forth in the Registration
   Statement and exhibits thereto which the Company has filed with the
   Commission under the Securities Act of 1933, as amended (the "Securities
   Act"), and to which reference is hereby made.


   INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE

      The following documents of the Company which have been filed with the
   Commission are hereby incorporated by reference in this Prospectus:

          (a) the Annual Report on Form 10-K for the year ended December 31,
      1995;

          (b) the Quarterly Report on Form 10-Q for the quarter ended March 31,
      1996;

          (c) the Current Reports on Form 8-K filed February 29, 1996 and
      February 1, 1996;

          (d)  the description of the Common Stock contained in Item 1 of the
      Registration Statement on Form 8-A dated September 20, 1991, and any
      amendment or report filed for the purpose of updating such description
      filed subsequent to the date of this Prospectus and prior to the
      termination of the offering described herein; and

      All documents filed by the Company pursuant to Section 13(a), 13(c), 14 or
   15(d) of the Exchange Act subsequent to the date of this Prospectus and prior
   to the termination of the offering of the Common Stock shall be deemed to be
   incorporated by reference into this Prospectus and to be a part hereof from
   the respective dates of filing of such documents. Any statement contained
   herein or in a document all or part of which is incorporated or deemed to be
   incorporated by reference herein shall be deemed to be modified or superseded
   for purposes of this Prospectus to the extent that a statement contained
   herein or in any subsequently filed document which also is or is deemed to be
   incorporated by reference herein modifies or supersedes such statement. Any
   such statement so modified or superseded shall not be deemed, except as so
   modified or superseded, to constitute a part of this Prospectus.

      The Company will provide without charge to any person to whom this
   Prospectus is delivered, upon the written or oral request of such person, a
   copy of any or all of the foregoing documents incorporated herein by
   reference (other than certain exhibits to such documents). Requests for such
   copies should be directed to Kevin H. Roche, Esq., General Counsel, United
   HealthCare Corporation, 300 Opus Center, 9900 Bren Road East, Minnetonka,
   Minnesota 55343, telephone number (612) 936-1736. In order to ensure timely
   delivery of documents, any request should be made not less than five business
   days prior to the date on which the final investment decision must be made.

                                      -2-
<PAGE>
 

                         UNITED HEALTHCARE CORPORATION

      The Company is a national leader in offering health care coverage and
   related services through a broad continuum of products and services. The
   Company served over 40 million covered lives at December 31, 1995. The
   Company's products and services utilize a number of core capabilities,
   including medical information management, health care delivery management,
   health benefit administration, risk assessment and pricing, health benefit
   design and provider contracting and risk sharing. With these capabilities,
   the Company is able to provide comprehensive managed care services, such as
   health maintenance organization ("HMO"), insurance and self-funded health
   care coverage products, as well as unbundled health care management and cost
   containment products such as mental health and substance abuse services,
   utilization review services, specialized provider networks and employee
   assistance programs. As part of its ongoing acquisition program, the Company
   acquired The MetraHealth Companies, Inc. ("MetraHealth") on October 2, 1995.
   MetraHealth is a managed health care coverage company and health insurer with
   over ten million covered lives at the time of the acquisition. As a result of
   the MetraHealth acquisition, the Company increased the geographic and product
   scope of its health care coverage business and now has relationships with
   many of the country's largest companies. On April 12, 1996, the Company
   acquired HealthWise of America, Inc. ("HealthWise"), a provider of a broad
   range of managed health care services to approximately 144,000 members
   through HMOs in Kentucky, Maryland, Tennessee and Arkansas. The acquisition
   of HealthWise will, among other things, enhance the Company's position in the
   Kentucky and Maryland markets.

      The Company is a Minnesota corporation, incorporated in January 1977. The
   principal executive offices of the Company are located at 300 Opus Center,
   9900 Bren Road East, Minnetonka, Minnesota 55343, and the telephone number is
   (612) 936-1300.

                                USE OF PROCEEDS

      The Company cannot predict the proceeds from the exercise of the warrants
   which have been offered. The Company estimates that if all outstanding
   warrants were exercised, the net proceeds to the Company would be
   approximately $564,221.  Any net proceeds actually received from the sale or
   exercise of warrants will be used for general corporate purposes.

                                      -3-
<PAGE>
 

                               PLAN OF OFFERING

      The Company assumed in connection with its merger with HealthWise of
   America, Inc. outstanding warrants to purchase the equivalent of 22,135
   shares of the Company Common Stock. These warrants are immediately
   exercisable at a price of $25.49 per share and expire on April 1, 1999. The
   persons holding these warrants, and the number of Shares of Common Stock
   subject to the warrant held by each individual, are set forth below:

 
                     Name                  Number of Shares
                     ----                  ----------------

                 Durwood B. Allen                  777
                 Edwin Barron                      388
                 Francisco Barres                  194
                 Richard Bronfman                  194
                 Jeff Carfagno                     388
                 Robert Casper                     582
                 James Comerford                   194
                 James Cooper                      777
                 Michael Cope                      777
                 David Coussens                    388
                 Philip Deer                       388
                 Jay Flaming                       194
                 Mark Gibbs                        388
                 Jay Holland                       777
                 B. E. Holmes                      194
                 Richard Johnson                   777
                 Garry Jones                       388
                 Ralph Joseph                      777
                 William Joseph                    388
                 Robert Lehmberg                   777
                 Derek Lewis                       777
                 David McKelvey                    777
                 Forrest Miller                    777
                 Keith Mooney                      388
                 James Morse                       777
                 Patrick Osam                      388
                 Robert Overacre                   388
                 Wendy Pardew                      777
                 Clifton Parnell                   388
                 Carl Raque                        194
                 William Riley                     777
                 Juan Roman                        388
                 Michael Selby                     777
                 Kemp Skokos                       777
                 Walt Stallings                    388
                 Brian Sudderth                    777
                 Samuel Taggart                    777
                 Kirk Watson                       194
                 David Wilkes                      388
                 Dennis Yelvington                 777
                 Robert Young                      777



                                      -4-
<PAGE>
 

                                    EXPERTS

The consolidated balance sheets as of December 31, 1995 and 1994 and the
consolidated statements of operations, shareholders equity and cash flows for
each of the three years in the period ended December 31, 1995 have been audited
by Arther Anderson LLP, independent public accountants, as indicated in their
report with respect thereto, and new Rida 5A incorporated herein by reference in
reliance upon the authority of said firm as experts in giving said report.

With respect to the unaudited interim financial information for the quarters 
ended March 31, 1996 and 1995, Arthur Andersen LLP has applied limited 
procedures in accordance with professional standards for a review of that 
information. However, their separate report thereon states that they did not 
audit and they do not express an opinion on that interim financial information. 
Accordingly, the degree of reliance on their report on that information should 
be restricted in light of the limited nature of the review procedures applied.
In addition, the accountants are not subject to the liability provisions of
Section 11 of the Securities Act of 1933 for their report on the unaudited
interim financial information because that report is not a "report" or a "part"
of the registration statement prepared or certified by the accountants within
the meaning of Sections 7 and 11 of the Act.

                                 LEGAL MATTERS

      The validity of the Shares offered hereby has been passed upon for the
   Company by Kevin H. Roche, General Counsel of the Company.


                                      -5-
<PAGE>
 

                                   PART II.

                    INFORMATION NOT REQUIRED IN PROSPECTUS


   ITEM 14.  OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION

        SEC Registration Fee..........  $  411
        Accounting Fees and Expenses..   1,500
        Legal Fees and Expenses.......   3,000
        Miscellaneous.................     589
             Total....................  $5,500

      All fees and expenses other than the SEC registration fee are estimated.
   The expenses listed above will be paid by the Company.

   ITEM 15.  INDEMNIFICATION OF DIRECTORS AND OFFICERS

      Minnesota Statutes Section 302A.521 provides that a corporation shall
   indemnify any person made or threatened to be made a party to a proceeding by
   reason of the former or present official capacity of such person against
   judgments, penalties, fines (including, without limitation, excise taxes
   assessed against such person with respect to any employee benefit plan),
   settlements and reasonable expenses, including attorneys' fees and
   disbursements, incurred by such person in connection with the proceeding, if,
   with respect to the acts or omissions of such person complained of in the
   proceeding, such person (1) has not been indemnified therefor by another
   organization or employee benefit plan; (2) acted in good faith; (3) received
   no improper personal benefit and Section 302A.255 (with respect to director
   conflicts of interest), if applicable, has been satisfied; (4) in the case of
   a criminal proceeding, had no reasonable cause to believe the conduct was
   unlawful; and (5) reasonably believed that the conduct was in the best
   interests of the corporation in the case of acts or omissions in such
   person's official capacity for the corporation or reasonably believed that
   the conduct was not opposed to the best interests of the corporation in the
   case of acts or omissions in such person's official capacity for other
   affiliated organizations. Article IX of the Bylaws of United provides that
   the Company shall indemnify officers and directors to the extent permitted by
   Section 302A.521 as now enacted or hereafter amended.

      The Company also carries a directors' and officers' liability insurance
   policy.

   ITEM 16.  LIST OF EXHIBITS

      5     Opinion of Kevin H. Roche, General Counsel of the Company, regarding
            legality.

      23.1  Consent of Arthur Andersen LLP relating to the consolidated
            financial statements of United HealthCare Corporation.

      23.2  Consent of Kevin H. Roche (included in Exhibit 5 to this
            Registration Statement).

      24    Power of Attorney.


                                     II-1
<PAGE>
 

   ITEM 17.  UNDERTAKINGS

   The undersigned Registrant hereby undertakes:

        (a)  (1)  To file, during any period in which offers or sales are being
   made, a post-effective amendment to this Registration Statement:

             (A) To include any prospectus required by Section 10(a)(3) of the
   Securities Act of 1933;

             (B) To reflect in the prospectus any facts or events arising after
   the effective date of the registration statement (or the most recent post-
   effective amendment thereof) which, individually or in the aggregate,
   represent a fundamental change in the information set forth in the
   registration statement. Notwithstanding the foregoing, any increase or
   decrease in volume of securities offered (if the total dollar value of
   securities offered would not exceed that which was registered) and any
   deviation from the low or high end of the estimated maximum offering range
   may be reflected in the form of prospectus filed with the Commission pursuant
   to Rule 424(b) if, in the aggregate, the changes in volume and price
   represent no more than a 20% change in the maximum aggregate offering price
   set forth in the "Calculation of Registration Fee" table in the effective
   Registration Statement.

             (C) To include any material information with respect to the plan of
   distribution not previously disclosed in the registration statement or any
   material change to such information in the registration statement;

             Provided, however, that paragraphs (a)(1)(A) and (a)(1)(B) do not
             apply if the information required to be included in a post-
             effective amendment by those paragraphs is contained in periodic
             reports filed by the registrant pursuant to section 13 or section
             15(d) of the Securities Exchange Act of 1934 that are incorporated
             by reference in the registration statement.

             (2) That, for the purpose of determining any liability under the
             Securities Act of 1933, each such post-effective amendment shall be
             deemed to be a new registration statement relating to the
             securities offered therein, and the offering of such securities at
             that time shall be deemed to be the initial bona fide offering
             thereof.

             (3) To remove from registration by means of a post-effective
             amendment any of the securities being registered which remain
             unsold at the termination of the offering.

      (b) Insofar as indemnification for liabilities arising under the
   Securities Act may be permitted to directors, officers and controlling
   persons of the Registrant pursuant to the foregoing provisions, or otherwise,
   the Registrant has been advised that in the opinion of the Securities and
   Exchange Commission such indemnification is against public policy as
   expressed in the Act and is, therefore, unenforceable. In the event that a
   claim for indemnification against such liabilities (other than the payment by
   the Registrant of expenses incurred or paid by a director, officer or
   controlling person of the Registrant in the successful defense of any action,
   suit or proceeding) is asserted by such director, officer or controlling
   person in connection with the securities being registered, the Registrant
   will, unless in the opinion of its counsel the matter has been settled by
   controlling precedent, submit to a court of appropriate jurisdiction the
   question whether such indemnification by it is against public policy as
   expressed in the Act and will be governed by the final adjudication of such
   issue.

                                     II-2
<PAGE>
 

      (c) For purposes of determining any liability under the Securities Act,
   each filing of the registrant's annual report pursuant to section 13(a) or
   section 15(d) of the Exchange Act (and, where applicable, each filing of an
   employee benefit plan's annual report pursuant to section 15(d) of the
   Exchange Act) that is incorporated by reference in the Registration Statement
   shall be deemed to be a new Registration Statement relating to the securities
   offered therein, and the offering of such securities at that time shall be
   deemed to be the initial bona fide offering thereof.







                                     II-3
<PAGE>
 

                                  SIGNATURES

      Pursuant to the requirements of the Securities Act of 1933, the registrant
   certifies that it has reasonable grounds to believe that it meets all of the
   requirements for filing on Form S-3 and has duly caused this amendment to the
   registration statement to be signed on its behalf by the undersigned,
   thereunto duly authorized, in the City of Minnetonka, State of Minnesota, 
   May 23, 1996.


                                       UNITED HEALTHCARE CORPORATION


                                       By /s/ William W. McGuire, M.D.
                                          -------------------------------
                                          William W. McGuire, M.D.
                                          Chief Executive Officer


      Pursuant to the requirements of the Securities Act of 1933, this Form S-3
   Registration Statement has been signed by the following persons in the
   capacities indicated on May 23, 1996.


   By /s/ William W. McGuire, M.D.
      -----------------------------------
      William W. McGuire, M.D.
      Director, Chief Executive Officer
      (principal executive officer)


   By /s/ David P. Koppe
      -----------------------------------
      David P. Koppe
      Chief Financial Officer
      (principal financial officer)


   By             *
      -----------------------------------
      William C. Ballard, Jr.
      Director


   By             *
      -----------------------------------
      Richard T. Burke
      Director


   By             *
      -----------------------------------
      James A. Johnson
      Director


   By             *
      -----------------------------------
      Douglas W. Leatherdale
      Director


   By             *
      -----------------------------------
      Kennett L. Simmons
      Director

                                     II-4
<PAGE>
 

   By             *
      -----------------------------------
        William G. Spears
        Director


   By             *
      -----------------------------------
        Gail R. Wilensky
        Director


   By             *
      -----------------------------------
        Thomas H. Kean
        Director




   By /s/ William W. McGuire, M.D.
      -----------------------------------
      William W. McGuire, M.D.
      As Attorney-In-Fact



                                     II-5
<PAGE>
 

                                 EXHIBIT INDEX
                                 -------------

Exhibit
Number        Description
- ------        -----------
          
          
   5          Opinion of Kevin H. Roche, General Counsel of the Company,
              regarding legality.
          
23.1          Consent of Arthur Andersen LLP relating to the consolidated
              financial statements of United HealthCare Corporation.
              
23.2          Consent of Kevin H. Roche (included in Exhibit 5 to this
              Registration Statement).
          
  24          Power of Attorney.

<PAGE>
 

                                                                       EXHIBIT 5

                                 May 23, 1996

   Securities and Exchange Commission
   Judiciary Plaza
   450 Fifth Street, N.W.
   Washington, D.C. 20549

         Re:     United HealthCare Corporation
                 22,135 Shares of Common Stock
                 Form S-3 Registration Statement

   Ladies and Gentlemen:

        I am General Counsel for United HealthCare Corporation ("UHC"), a
   Minnesota corporation. UHC is filing a Registration Statement on Form S-3
   (the "Registration Statement") covering the sale of 22,135 shares of the
   common stock, $.01 par value (the "Common Stock") of UHC pursuant to warrants
   UHC assumed in connection with a merger with HealthWise of America, Inc.
   ("HealthWise").

        In connection with the rendering of this opinion, I, or members of my
   staff, have examined originals or copies, certified or otherwise identified
   to my satisfaction, of such instruments, documents, certificates, agreements
   and records as I have deemed necessary or appropriate under the circumstances
   for the purpose of rendering this opinion. In so acting, I have examined and
   relied upon the accuracy of original, certified, conformed, photostatic, or
   telecopied copies of such instruments, documents, certificates, agreements
   and records. In all such examinations, I have assumed the genuineness and due
   authorization of all signatures on, and the authenticity and completeness of,
   all documents submitted to me as originals, and the conformity to such
   original documents of all copies submitted to me as copies, and the veracity
   and completeness of statements, both written and oral, made by officers or
   other representatives of UHC and HealthWise. As to various questions of fact
   material to my opinion, I have relied upon the veracity of the factual
   representations made by UHC and HealthWise in certificates and in other
   statements, both written and oral, from officers and other representatives of
   UHC and HealthWise, and upon certificates and other written or telephonic
   statements of public officials, and I have assumed that the facts and
   circumstances contained in such certificates and other statements are true
   and complete and have not changed since the date thereof. I have assumed that
   all conditions precedent to the obligations of the parties to consummate the
   transactions under the Merger Agreement have been satisfied or waived. I have
   also assumed the legal capacity for all purposes relevant hereto of all
   natural persons and, with respect to all parties to agreements or instruments
   relevant hereto other than UHC, that such parties had the requisite power and
   authority (corporate or otherwise) to execute, deliver and perform such
   agreements or instruments, that such agreements or instruments have been duly
   authorized by all requisite action (corporate or otherwise), executed and
   delivered by such parties and that such agreements or instruments are the
   valid, binding and enforceable obligations of such parties. I have also
   assumed that the Common Stock will be issued as described in the Registration
   Statement.

        Based on the foregoing, I am of the opinion that the shares of Common
   Stock to be issued by UHC in connection with the Registration Statement, when
   issued will be duly authorized, validly issued, fully paid and nonassessable.

        This opinion is given as of the date set forth above and I assume no
   obligation to advise you of any changes, whether or not material, which may
   be brought to my attention at a later date. This opinion is limited to the
   matters stated herein and no opinion is implied or may be inferred beyond the
   matters expressly stated herein.

        I am a member of the Bar of the State of Minnesota only and do not hold
   myself out as an expert on the law of any other state or of any foreign
   county. This opinion is rendered solely for, and may be
<PAGE>
 

   relied upon only by, you in connection with the transaction the Registration
   Statement describes. Finally, this opinion may not be disseminated to, or
   relied upon by, any other person or entity for any other purpose without my
   prior written consent.

        I hereby consent to the filing of this opinion as an exhibit to the
   Registration Statement, and to the reference to me under the heading "Legal
   Matters" in the Prospectus constituting part of the Registration Statement.


                                            Sincerely,

                                            /s/ Kevin H. Roche

                                            Kevin H. Roche
                                            General Counsel

<PAGE>
 

                                                                    EXHIBIT 23.1

                    CONSENT OF INDEPENDENT PUBLIC ACCOUNTS


        As independent public accountants, we hereby consent to the
   incorporation by reference in this Registration Statement on Form S-3 of our
   report dated February 29, 1996 incorporated by reference in United HealthCare
   Corporation's Annual Report on Form 10-K for the year ended December 31, 1995
   and to all references to our Firm included in this Registration Statement.



                                            ARTHUR ANDERSEN LLP

   Minneapolis, Minnesota
   May 20, 1996

<PAGE>
 

                                                                      EXHIBIT 24

                               POWER OF ATTORNEY

             KNOW ALL BY THESE PRESENTS that each person whose signature appears
   below constitutes and appoints each of William W. McGuire, M.D., David P.
   Koppe and Kevin H. Roche, each with full power to act without the other, his
   or her true and lawful attorney-in-fact and agent with full power of
   substitution, for him or her and in his or her name, place and stead, in any
   and all capacities, to sign the Registration Statement on Form S-3 relating
   to the registration under the Securities Act of 1933 of the sale of common
   stock of United HealthCare Corporation (the "Company") pursuant to warrants
   the Company assumed in connection with its merger with HealthWise of America,
   Inc., and any or all amendments or post-effective amendments thereto, and to
   file the same, with all exhibits to such Registration Statement, and other
   documents in connection therewith, with the Securities and Exchange
   Commission, and to file the same with such state commissions and other
   agencies as necessary, granting unto each such attorney-in-fact and agent
   full power and authority to do and perform each and every act and thing
   requisite and necessary to be done in and about the premises, as fully to all
   intents and purposes as he or she might or could do in person, hereby
   ratifying and confirming all that each such attorney-in-fact and agent, or
   his substitute, may lawfully do or cause to be done by virtue hereof.

             IN WITNESS WHEREOF, this Power of Attorney has been signed on the
   17th day of May, 1996, by the following persons.



/s/ William W. McGuire, M.D.            /s/ Douglas W. Leatherdale
- ------------------------------          ---------------------------------
William W. McGuire, M.D.                Douglas W. Leatherdale
                                   
                                   
/s/ David P. Koppe 
- ------------------------------          ---------------------------------
David P. Koppe                          Elizabeth J. McCormack
                                   
                                   
/s/ William C. Ballard, Jr.             /s/ Gail R. Wilensky
- ------------------------------          ---------------------------------
William C. Ballard, Jr.                 Gail R. Wilensky
                                   
                                   
/s/ Richard T. Burke                    /s/ William G. Spears
- ------------------------------          ---------------------------------
Richard T. Burke                        William G. Spears
                                   
                                   
/s/ James A. Johnson                    /s/ Kennett L. Simmons
- ------------------------------          ---------------------------------
James A. Johnson                        Kennett L. Simmons


/s/ Thomas H. Kean
- ------------------------------ 
Thomas H. Kean


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission